Mangoceuticals Inc

NAS:MGRX (USA)  
$ 2.52 +0.04 (+1.61%) 11:09 PM EST
At Loss
P/B:
0.40
Volume:
31.54K
Avg Vol (2M):
103.96K
Trade In:
Volume:
31.54K
At Loss
Avg Vol (2M):
103.96K

Business Description

Mangoceuticals Inc
NAICS : 923120 SIC : 7372
ISIN : US56270V1061
Description
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
Name Current Vs Industry Vs History
Cash-To-Debt 0.28
Equity-to-Asset 0.91
Debt-to-Equity 0.02
Debt-to-EBITDA -0.03
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -1.05
Distress
Grey
Safe
Beneish M-Score 33.91
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 55.21
9-Day RSI 51.93
14-Day RSI 49.91
6-1 Month Momentum % -46.46
12-1 Month Momentum % -39.08

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.07
Quick Ratio 0.07
Cash Ratio 0.05
Days Inventory 19.25
Days Payable 646.44

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % -8.94
Name Current Vs Industry Vs History
Gross Margin % 58.75
Operating Margin % -1175.46
Net Margin % -1236.87
FCF Margin % -720.42
ROE % -164.24
ROA % -141.4
ROIC % -143.44
ROC (Joel Greenblatt) % -5365.01
ROCE % -154.8

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 5.17
PB Ratio 0.4
EV-to-EBIT -0.72
EV-to-EBITDA -0.72
EV-to-Revenue 8.44
EV-to-FCF -1.17
Earnings Yield (Greenblatt) % -138.89
FCF Yield % -86.68

Financials (Next Earnings Date:2025-03-01 Est.)

MGRX's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:MGRX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Mangoceuticals Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.754
EPS (TTM) ($) -5.71
Beta 0
Volatility % 124.23
14-Day RSI 49.91
14-Day ATR ($) 0.17416
20-Day SMA ($) 2.508745
12-1 Month Momentum % -39.08
52-Week Range ($) 2.1 - 16.799999
Shares Outstanding (Mil) 2.49

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Mangoceuticals Inc Filings

Filing Date Document Date Form
No Filing Data

Mangoceuticals Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Mangoceuticals Inc Frequently Asked Questions

What is Mangoceuticals Inc(MGRX)'s stock price today?
The current price of MGRX is $2.52. The 52 week high of MGRX is $16.80 and 52 week low is $2.10.
When is next earnings date of Mangoceuticals Inc(MGRX)?
The next earnings date of Mangoceuticals Inc(MGRX) is 2025-03-01 Est..
Does Mangoceuticals Inc(MGRX) pay dividends? If so, how much?
Mangoceuticals Inc(MGRX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1